NEW YORK, NY / ACCESSWIRE / November 18, 2020 / Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders interested in serving as lead plaintiff have until the deadlines listed to petition the court. Further details about the cases can be found at the links provided. There is no cost or obligation to you.
FLDM Shareholders Click Here: https://www.zlk.com/pslra-1/fluidigm-corporation-information-request-form?prid=11026&wire=1
TRQ Shareholders Click Here: https://www.zlk.com/pslra-1/turquoise-hill-resources-ltd-loss-submission-form?prid=11026&wire=1
BIIB Shareholders Click Here: https://www.zlk.com/pslra-1/biogen-inc-loss-submission-form?prid=11026&wire=1
* ADDITIONAL INFORMATION BELOW *
Fluidigm Corporation (NASDAQ:FLDM)
FLDM Lawsuit on behalf of: investors who purchased February 7, 2019 - November 5, 2019
Lead Plaintiff Deadline: November 20, 2020
TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/fluidigm-corporation-information-request-form?prid=11026&wire=1
According to the filed complaint, during the class period, Fluidigm Corporation made materially false and/or misleading statements and/or failed to disclose that: (1) Fluidigm was experiencing longer sales cycles; (2) as a result, Fluidigm's revenue was reasonably likely to decline; and (3) as a result of the foregoing, Defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis.
Turquoise Hill Resources Ltd. (NYSE:TRQ)
TRQ Lawsuit on behalf of: investors who purchased July 17, 2018 - July 31, 2019
Lead Plaintiff Deadline: December 14, 2020
TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/turquoise-hill-resources-ltd-loss-submission-form?prid=11026&wire=1
According to the filed complaint, during the class period, Turquoise Hill Resources Ltd. made materially false and/or misleading statements and/or failed to disclose that: (i) the progress of underground development of Oyu Tolgoi was not proceeding as planned; (ii) there were significant undisclosed underground stability issues that called into question the design of the mine, the projected cost and timing of production; (iii) the company's publicly disclosed estimates of the cost, date of completion and dates for production from the underground mine were not achievable; (iv) the development capital required for the underground development of Oyu Tolgoi would cost substantially more than a billion dollars over what the company had represented; and (v) Turquoise Hill would require additional financing and/or equity to complete the project.
Biogen Inc. (NASDAQ:BIIB)
BIIB Lawsuit on behalf of: investors who purchased October 22, 2019 - November 6, 2019
Lead Plaintiff Deadline: January 12, 2021
TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/biogen-inc-loss-submission-form?prid=11026&wire=1
According to the filed complaint, during the class period, Biogen Inc. made materially false and/or misleading statements and/or failed to disclose that: (1) the larger dataset did not provide necessary data regarding aducanumab's effectiveness; (2) the EMERGE study did not and would not provide necessary data regarding the effectiveness of aducanumab, Biogen's investigational human monoclonal antibody studied for the treatment of early Alzheimer's disease; (3) the PRIME study did not and would not provide necessary data regarding aducanumab's effectiveness; (4) the data provided by the Company to the U.S. Food and Drug Administration's Peripheral and Central Nervous System Drugs Advisory Committee did not support finding efficacy of aducanumab; and (5) as a result, Defendants' statements about its business, operations, and prospects, were materially false and misleading and/or lacked a reasonable basis at all relevant times.
You have until the lead plaintiff deadlines to request that the court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.
Levi & Korsinsky is a nationally recognized firm with offices in New York, California, Connecticut, and Washington D.C. The firm's attorneys have extensive expertise and experience representing investors in securities litigation and have recovered hundreds of millions of dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT:
Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
55 Broadway, 10th Floor
New York, NY 10006
[email protected]
Tel: (212) 363-7500
Fax: (212) 363-7171
www.zlk.com
SOURCE: Levi & Korsinsky, LLP